Barfresh Food (BRFH) 10-Q 13 Feb 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Dec. 31, 2013	Feb. 13, 2014
Document And Entity Information	'	'
Entity Registrant Name	'BARFRESH FOOD GROUP INC.	'
Entity Central Index Key	'0001487197	'
Document Type	'10-Q	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--03-31	'
Entity's Current Reporting Status	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	59,592,660
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Dec. 31, 2013	Mar. 31, 2013
Current assets:	'	'
Cash	$664,484	$85,957
Accounts Receivable	4,984	7,413
Receivable from related party	'	13,540
Inventory	61,427	12,712
Prepaid expenses and other current assets	19,137	226,602
Total current assets	750,032	346,224
Property, plant and equipment, net of depreciation	315,342	311,496
Intangible asset, net of amortization	713,327	31,985
Deposits	14,461	10,731
Total Assets	1,793,162	700,436
Current liabilities:	'	'
Accounts payable	124,101	247,682
Accrued expenses	216,423	187,096
Deferred rent liability	2,666	5,066
Advances from related party	'	30,272
Short-term notes payable - related party, net of discount	436,985	'
Short-term notes payable, net of discount	46,811	'
Convertible note - related party, net of discount	'	36,551
Convertible note, net of discount	'	285,100
Total current liabilities	826,986	791,767
Convertible note - related party, net of discount	20,569	'
Convertible note, net of discount	152,115	'
Total liabilities	999,670	791,767
Commitments and contingencies	'	'
Stockholders' equity (deficit):	'	'
Preferred stock, $0.000001 par value, 5,000,000 shares authorized, none issued or outstanding	'	'
Common stock, $0.000001 par value; 95,000,000 shares authorized; 59,592,660 and 50,366,660 shares issued and outstanding at December 31 and March 31, 2013, respectively	59	50
Additional paid in capital	4,842,949	2,355,328
Accumulated deficit	-4,049,516	-2,446,709
Total stockholders' equity (deficit)	793,492	-91,331
Total Liabilities and Stockholders' Equity (Deficit)	$1,793,162	$700,436

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2013	Mar. 31, 2013
Statement of Financial Position [Abstract]	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	95,000,000	95,000,000
Common stock, shares issued	59,592,660	50,366,660
Common stock, shares outstanding	59,592,660	50,366,660

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Income Statement [Abstract]	'	'	'	'
Revenue	$7,541	$4,608	$39,799	$7,488
Cost of revenue	4,414	3,859	25,733	6,115
Gross profit	3,127	749	14,066	1,373
Operating expenses:	'	'	'	'
General and administrative	462,799	581,346	1,365,431	1,216,059
Depreciation Amortization	27,652	10,390	56,129	17,436
Total operating expenses	490,451	591,736	1,421,560	1,233,495
Operating loss	-487,324	-590,987	-1,407,494	-1,232,122
Other expenses	'	'	'	'
Interest	43,284	84,209	195,313	112,279
Net (loss)	($530,608)	($675,196)	($1,602,807)	($1,344,401)
Per share information - basic and fully diluted:	'	'	'	'
Weighted average shares outstanding	59,592,660	48,658,372	56,334,182	48,574,767
Net (loss) per share	($0.01)	($0.01)	($0.03)	($0.03)

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Statement of Cash Flows [Abstract]	'	'
Net cash used in operations	($1,443,739)	($541,246)
Cash flow from investing activities:	'	'
Purchase of patents	-697,157	'
Purchase of equipment	-44,160	-153,227
Net Cash used in investing activities	-741,317	-153,227
Cash flow from financing activities:	'	'
Issuance of common stock for cash	2,038,855	'
Issuance of convertible debt	20,000	440,000
Repayment of convertible debt	-40,000	'
Issuance of notes payable	775,000	'
Advance from related party	485,132	30,272
Repayment to related party	-515,404	'
Net cash provided by financing activities	2,763,583	470,272
Net increase (decrease) in cash	578,527	-224,201
Cash at beginning of period	85,957	420,976
Cash at end of period	664,484	196,775
Supplemental disclosure of cash flow information:	'	'
Cash paid for interest	55,009	'
Cash paid for income taxes	'	'
Non-cash financing activities:	'	'
Common stock issued for services/stock based compensation	'	479,797
Fair value of warrants issued with convertible notes	142,873	142,019
Value of beneficial conversion of convertible notes	125,905	142,019
Fair value of warrants issued with short-term notes payable	$298,232	'

Basis_of_Presentation

Basis of Presentation	9 Months Ended
	Dec. 31, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Basis of Presentation	'
	Note 1. Basis of Presentation
	Throughout this report, the terms “our”, “we”, “us” and the “Company” refer to Barfresh Food Group Inc., including its subsidiaries. The accompanying unaudited condensed financial statements of Barfresh Food Group Inc. at December 31, 2013 and 2012 have been prepared in accordance with generally accepted accounting principles (“GAAP”) for interim financial statements, instructions to Form 10-Q, and Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the financial statements and notes thereto included in our annual report on Form 10-K for the year ended March 31, 2013. In management’s opinion, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation to make our financial statements not misleading have been included. The results of operations for the periods ended December 31, 2013 and 2012 presented are not necessarily indicative of the results to be expected for the full year. The March 31, 2013 balance sheet has been derived from our audited financial statements included in our annual report on Form 10-K for the year ended March 31, 2013.
	We were in the development stage from December 4, 2009 through March 31, 2013. Our fiscal year ending March 31, 2014 is the first year during which we are considered an operating company and no longer in the development stage.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	9 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Note 2. Summary of Significant Accounting Policies
	The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which contemplates our continuation as a going concern. We have incurred losses to date of $4,049,516. To date we have funded our operations through advances from a related party, issuance of debt, and the sale of our common stock. We intend to raise additional funding through third party equity or debt financing. There is no certainty that funding will be available as needed. These factors raise substantial doubt about our ability to continue operating as a going concern. Our ability to continue our operations as a going concern, realize the carrying value of our assets, and discharge our liabilities in the normal course of business is dependent upon our ability to raise capital sufficient to fund our commitments and ongoing losses and ultimately generate profitable operations.
	Basis of Consolidation
	The consolidated condensed financial statements include the financial statements of the Company and our wholly owned subsidiaries Barfresh Inc. and Smoothie Inc. All inter-company balances and transactions among the companies have been eliminated upon consolidation.
	Intangible Assets
	Intangible assets are comprised of patents, net of amortization. The patent costs are being amortized over the life of the patents, which is twenty years from the date of filing the patent applications. In accordance with ASC Topic 350 Intangibles - Goodwill and Other (“ASC 350”), the costs of internally developing other intangible assets, such as patents, are expensed as incurred. However, as allowed by ASC 350, legal fees and similar costs relating to patents have been capitalized.
	Property, Plant and Equipment
	Property, plant and equipment is stated at cost less accumulated depreciation and accumulated impairment loss, if any. Depreciation is calculated on a straight line basis over the estimated useful lives of the assets. Leasehold improvements are being amortized over the shorter of the useful life of the asset or the lease term that includes any expected renewal periods deemed to be reasonably assured. The estimated useful lives used for financial statement purposes are:
	Furniture and fixtures: 5 years
	Equipment: 7 years
	Leasehold improvements: 2 years
	Revenue Recognition
	We recognize revenue when there is persuasive evidence of an arrangement, delivery has occurred or services have been rendered, the sales price is determinable and collection is reasonably assured.
	Use of Estimates
	The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.
	Earnings per Share
	We calculate net loss per share in accordance with ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, and diluted earnings per share is computed by including common stock equivalents outstanding for the period in the denominator. At December 31, 2013 and 2012 any equivalents would have been anti-dilutive as we had losses for the periods then ended.
	Research and Development
	Expenditures for research activities relating to product development and improvement are charged to expense as incurred. We incurred $40,305 and $55,233 in research and development expenses for the nine months ended December 31, 2013 and 2012, respectively, and $31,866 and $43,004 in research and development expenses for the three months ended December 31, 2013 and 2012, respectively.
	Rent Expense
	We recognize rent expense on a straight-line basis over the reasonably assured lease term as defined in ASC Topic 840, Leases (“ASC 840”). In addition, our lease agreement provides for rental payments commencing at a date other than the date of initial occupancy. We include the rent holidays in determination of straight-line rent expense. Therefore, rent expense is charged to expense beginning with the occupancy date. Deferred rent was $2,666 and $5,066 at December 31, 2013 and March 31, 2013, respectively, and will be charged to rent expense over the life of the lease.
	Recent Pronouncements
	We have reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoptions of any such pronouncements may be expected to cause a material impact on our financial condition or results of operations.

Property_Plant_and_Equipment

Property Plant and Equipment	9 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Property Plant and Equipment	'
	Note 3. Property Plant and Equipment
	Major classes of property and equipment consist of the following:
		31-Dec-13			31-Mar-13
	Furniture and fixtures	$	13,331		$	11,070
	Equipment		372,220			330,321
	Leasehold Improvements		3,300			3,300
			388,851			344,691
	Less: accumulated depreciation		(73,509	)		(33,195	)
		$	315,342		$	311,496
	We recorded depreciation expense related to these assets of $40,314 and $15,801 for the nine months ended December 31, 2013 and 2012, respectively, and $12,928 and $9,846 for the three months ended December 31, 2013 and 2012, respectively.

Intangible_Assets

Intangible Assets	9 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Intangible Assets	'
	Note 4. Intangible Assets
	As of December 31, 2013 and March 31, 2013, intangible assets consist of patent costs of $734,244 and $37,087, less accumulated amortization of $20,917 and $5,102, respectively.
	Estimated amortization expense related to the patent as of December 31, 2013 is as follows:
	Fiscal Years ending March 31,	Total Amortization
	2014 (three months remaining)	$	15,077
	2015		60,307
	2016		60,307
	2017		60,307
	2018		60,307
	Later years		457,022
		$	713,327

Advance_from_Related_Party

Advance from Related Party	9 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
Advance from Related Party	'
	Note 5. Advance from Related Party
	During the nine months ended December 31, 2013 we received a cash advance from an affiliate of a director and shareholder of the Company in the amount of $445,157, which was used for the purchase of certain international patent rights. The advance was repaid with interest calculated at 6.0% per annum ($5,617).
	During the nine months ended December 31, 2013 and the year ended March 31, 2013 we received cash advances in the amounts of $12,975 and $30,272, respectively, from a relative of an officer of the Company. The advances bear no interest and were repaid.

ShortTerm_Notes_Payable_Relate

Short-Term Notes Payable (Related and Unrelated)	9 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Short-Term Notes Payable (Related and Unrelated)	'
	Note 6. Short-Term Notes Payable (Related and Unrelated)
	In December 2013, we closed an offering of $775,000 in short-term notes payable (“Short-Term Notes”), $500,000 of which was purchased by a significant shareholder, $100,000 was purchased by an officer, director and significant shareholder and $100,000 was purchased by a director and significant shareholder. The Short-Term Notes bear interest at a rate of 2% per annum and are due and payable on December 20, 2014. We also issued 1,291,667 warrants to the Short-Term Note holders for the right to purchase shares of our common stock. Each warrant entitles the holder to purchase one share of our common stock at a price of $0.45 per share, may be exercised on a cashless basis and are exercisable for a period of five years.
	In accordance with the guidance in ASC Topic 470-20 Debt with Conversion and Other Options (“ASC 470”), we first calculated the fair value of the warrants issued and then determined the relative value of the Short-Term Notes.
	The fair value of the warrant, $0.38 per share, was calculated using the Black-Sholes option pricing model using the following assumptions:
	Expected life (in years)		5
	Volatility (based on a comparable company)		97	%
	Risk Free interest rate		1.66	%
	Dividend yield (on common stock)		-
	The relative value of the warrants was $298,232, which was the amount recorded as debt discount. The amounts recorded as debt discount will be amortized over the life of the note, one year, and charged to interest expense. We estimated the effective interest rate as calculated to be approximately 52% but will be paying cash at a rate of 2% per annum.
	The balance at December 31, 2013 was comprised of:
	Convertible notes payable, related and unrelated parties	$	775,000
	Unamortized Debt discount		(291,204	)
		$	483,796
	Accrued expenses include interest of $467 at December 31, 2013.
	We have the right to extend the due date of the Short-Term Notes to June 19, 2014 with notice to the holders given at least 30 days and no more than 60 days prior to the initial due date. If we extend the Short-Term Notes the interest rate will increase to 3% per annum and we will be required to issue additional warrants (“Extension Warrants”). The Extension Warrants will have a 3 year term and the exercise price will be determined based on the volume weighted average price for the 10 trading days preceding the original due date of the Short-Term Notes. The number of shares which may be purchased will be computed by dividing 56.25% of the unpaid principal amount of the Short-Term Notes held by the initial exercise price computed as set forth above.

Convertible_Note_Related_and_U

Convertible Note (Related and Unrelated)	9 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Convertible Note (Related and Unrelated)	'
	Note 7. Convertible Note (Related and Unrelated)
	In August 2012, we closed an offering of $440,000 of convertible notes, $50,000 of which was purchased by a significant shareholder of ours. The notes bear interest at a rate of 12% per annum and are due and payable on September 6, 2013. In addition, the notes are convertible at any time after the original issue date until the notes are no longer outstanding into our common stock at a conversion price of $0.372 per share. We also issued 956,519 warrants to the note holders for the right to purchase shares of our common stock. Each warrant entitles the holder to purchase one share of our common stock at a price of $0.46 per share for a term of seven years.
	When the convertible notes were due we settled the notes by repaying $40,000 of the notes in cash, issuing new convertible notes in the amount of $400,000 and received payment for another note in the amount of $20,000. The new notes bear interest at a rate of 12% per annum and are due and payable on September 6, 2015. In addition the new notes are convertible at any time after the original issue date until the new notes are no longer outstanding, into our common stock at a conversion price of $0.25 per share. We also issued warrants to the new note holders for the right to purchase shares of our common stock. Each warrant entitles the holder to purchase one share of our common stock at a price of $0.25 per share. There were 1,680,000 warrants issued.
	In accordance with the guidance in ASC Topic 470-20 Debt with Conversion and Other Options (“ASC 470”), we first calculated the fair value of the warrants issued and then determined the relative value of the notes and determined that there was a beneficial conversion feature.
	The fair value of the warrants, $0.13 per share, ($216,531 in the aggregate) was calculated using the Black-Sholes option pricing model using the following assumptions:
	Expected life (in years)		3
	Volatility (based on a comparable company)		85	%
	Risk Free interest rate		0.91	%
	Dividend yield (on common stock)		-
	The relative value of the warrants to the notes was $142,873, which was the amount recorded as a portion of the debt discount. We also recorded a beneficial conversion feature on the convertible notes of $125,905. The amounts recorded as debt discount will be amortized over the life of the notes, two years, and charged to interest expense. We estimated the effective interest rate as calculated to be approximately 74% but will be paying cash at a rate of 12% per annum.
	The balance at December 31, 2013 was comprised of:
	Convertible notes payable, related and unrelated parties	$	420,000
	Unamortized Debt discount		(247,316	)
		$	172,684
	Accrued expenses include interest of $16,017 at December 31, 2013.
	The aggregate amount of principal payments due as of December 31, 2013 are as follows:
	Fiscal Years ending March 31,
	2014	$	-
	2015		775,000
	2016		420,000
		$	1,195,000

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Note 8. Commitments and Contingencies
	We lease office space under a non-cancelable operating lease, which expires October 31, 2014.
	The aggregate minimum requirements under non-cancelable leases as of December 31, 2013 are as follows:
	Fiscal Years ending March 31,
	2014 (three months remaining)	$	19,995
	2015		46,655
		$	66,650
	Rent expense was $62,209 and $21,984 for the nine months ended December 31, 2013 and 2012, respectively, and $22,257 and $19,601 for the three months ended December 31, 2013 and 2012, respectively.

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Dec. 31, 2013
Equity [Abstract]	'
Stockholders' Equity	'
	Note 9. Stockholders’ Equity
	During prior periods we issued 1,850,000 shares of our common stock to non-employees for various consulting services. Pursuant to the guidance in ASC Topic 505-50, Equity Based Payments to Non-Employees (“ASC 505-50”), the shares issued are being amortized over the periods of the contracts which range from one to two years. The shares were valued at the market price on the date of grant. The aggregate value of the shares previously issued was $596,500. The unamortized balance of $12,500, representing the vested portion not yet expensed, is included in prepaid expenses at December 31, 2013.
	During the nine months ended December 31, 2013, we terminated a contract with a non-employee. All previously unvested stock option expense attributed to the non-employee, in the amount of $14,747 was reversed and credited to general and administrative expenses
	We have consulting contracts which provide for the potential issuance of an additional 1,350,000 shares of our common stock at prices to be determined in the future. The contracts contain performance commitments relating to future revenue and/or earnings. There are not significantly large disincentives for nonperformance to make the achievement of the goals probable. None of the goals were achieved as of December 31, 2013, and in accordance with the guidance ASC 505-50, no expense was recognized for these future grants.
	Certain previously granted restricted stock rights and stock options were subject to performance conditions. As a result of the employee termination the performance conditions will not be met. In accordance with ASC Topic 718, Compensation - Stock Compensation (“ASC 718”), previously recognized unvested equity based compensation cost of $103,488 has been reversed during the nine months ended December 31, 2013.
	During the period from December 31, 2012 through May 9, 2013, we completed an offering of common stock units at a price of $0.25 per unit. Each unit consists of one share of common stock and a three year warrant to purchase one-half (1/2) share of our common stock at an exercise price of $0.50 per share (“Unit” or “Units”). We sold 3,200,000 units representing 3,200,000 shares and warrants to purchase 1,600,000 shares for total consideration of $800,000 less $17,500 in cost, for a net amount received of $782,500.
	The fair value of the warrants, $266,673, was estimated at the date of grant using the Black-Scholes option pricing model, with an allocation of the proceeds applied to the warrants. The difference between the warrant allocation and the proceeds was allocated to the shares of common stock issued. The fair value of the warrants has been included in the total additional paid in capital. The following assumptions were used in the Black-Scholes option pricing model:
	Expected life (in years)		3
	Volatility (based on a comparable company)		100	%
	Risk Free interest rate		0.36	%
	Dividend yield (on common stock)		-
	During July and August 2013 we completed an offering of common stock units at a price of $0.25 per unit. Each unit consists of one share of common stock, a three-year warrant to purchase one share of our common stock at an exercise price of $0.25 per share (which may be exercised on a cashless basis), and a five-year warrant to purchase one-half (1/2) share of our common stock at an exercise price of $0.50 per share (“Unit” or “Units) for total consideration of $1,906,500 less $267,645 in cost for a net amount received of $1,638,855.
	The fair value of the warrants, estimated at the date of grant using the Black-Scholes option pricing model was $3,089,919. The estimated value was higher than the proceeds received from the sale of the units. Accordingly, the proceeds received less the par value of the common stock, has been included in the total additional paid in capital. The following assumptions were used in the Black-Scholes option pricing model:
	Expected life (in years)		3 - 5
	Volatility (based on a comparable company)		87 - 106	%
	Risk Free interest rate		0.67 - 1.38	%
	Dividend yield (on common stock)		-
	The following is a summary of outstanding stock options issued to employees as of December 31, 2013
		Number of			Exercise		Average		Aggregate
		Options			price		remaining		intrinsic value
					per share		term in years		at date of grant
	Outstanding March 31, 2013		625,000		$	1		2.23	$	-
	Cancelled		(625,000	)		-		-		-
	Outstanding December 31, 2013		-			-		-		-
	Exercisable		-		$	-		-	$	-

Outstanding_Warrants

Outstanding Warrants	9 Months Ended
	Dec. 31, 2013
Outstanding Warrants	'
Outstanding Warrants	'
	Note 10. Outstanding Warrants
	The following is a summary of all outstanding warrants as of December 31, 2013:
		Number of		Exercise		Average		Aggregate
		warrants		price		remaining		intrinsic value
				per share		term in years		at date of grant
	Warrants issued in connection with private placements of common stock		14,372,232	$	0.25 - 1.50		3.1	$	1,296,420
	Warrants issued in connection with private placement of convertible notes		2,636,519	$	0.25 - 0.46		2.68 - 4.65	$	-
	Warrants issued in connection with short-term notes payable		1,291,667	$	0.45		4.97	$	64,583

Interest_Expense

Interest Expense	9 Months Ended
	Dec. 31, 2013
Interest Expense	'
Interest Expense	'
	Note 11. Interest Expense
	Interest expense includes direct interest of $48,474 and $18,067 for the nine and three months ended December 31, 2013, respectively, and $17,600 and $13,200 for the nine and three months ended December 31, 2012, respectively, calculated based on the interest rate stated in our various debt instruments.
	In addition as more fully described in Notes 6 and 7 above, interest expense includes non-cash amortization of the debt discount of $146,839 and $25,217 for the nine and three months ended December 31, 2013, respectively, and $94,679, and $65,369 for the nine and three months ended December 31, 2012, respectively.

Income_Taxes

Income Taxes	9 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 12. Income Taxes
	We account for income taxes in interim periods in accordance with ASC Topic 740, Income Taxes (“ASC 740”). We have determined an estimated annual effective tax rate. The rate will be revised, if necessary, as of the end of each successive interim period during our fiscal year to our best current estimate. As of December 31, 2013 the estimated effective tax rate for the year will be zero.
	There are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from 2009 through the current period. Our policy is to account for income tax related interest and penalties in income tax expense in the statement of operations. There have been no income tax related interest or penalties assessed or recorded.
	ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This pronouncement also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition.
	For the nine and three months ended December 31, 2013 and 2012 we did not have any interest and penalties associated with tax positions. As of December 31, 2013 we did not have any significant unrecognized uncertain tax positions.

Business_Segments

Business Segments	9 Months Ended
	Dec. 31, 2013
Segment Reporting [Abstract]	'
Business Segments	'
	Note 13. Business Segments
	We operate in only one segment and geographic location.

Subsequent_Events

Subsequent Events	9 Months Ended
	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Events	'
	Note 14. Subsequent Events
	Management has evaluated all activity and concluded that no subsequent events have occurred that would require recognition in the financial statements or disclosure in the notes to the financial statements

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Basis of Consolidation	'
	Basis of Consolidation
	The consolidated condensed financial statements include the financial statements of the Company and our wholly owned subsidiaries Barfresh Inc. and Smoothie Inc. All inter-company balances and transactions among the companies have been eliminated upon consolidation.
Intangible Assets	'
	Intangible Assets
	Intangible assets are comprised of patents, net of amortization. The patent costs are being amortized over the life of the patents, which is twenty years from the date of filing the patent applications. In accordance with ASC Topic 350 Intangibles - Goodwill and Other (“ASC 350”), the costs of internally developing other intangible assets, such as patents, are expensed as incurred. However, as allowed by ASC 350, legal fees and similar costs relating to patents have been capitalized.
Property, Plant and Equipment	'
	Property, Plant and Equipment
	Property, plant and equipment is stated at cost less accumulated depreciation and accumulated impairment loss, if any. Depreciation is calculated on a straight line basis over the estimated useful lives of the assets. Leasehold improvements are being amortized over the shorter of the useful life of the asset or the lease term that includes any expected renewal periods deemed to be reasonably assured. The estimated useful lives used for financial statement purposes are:
	Furniture and fixtures: 5 years
	Equipment: 7 years
	Leasehold improvements: 2 years
Revenue Recognition	'
	Revenue Recognition
	We recognize revenue when there is persuasive evidence of an arrangement, delivery has occurred or services have been rendered, the sales price is determinable and collection is reasonably assured.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ from these estimates.
Earnings per Share	'
	Earnings per Share
	We calculate net loss per share in accordance with ASC Topic 260, Earnings per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period, and diluted earnings per share is computed by including common stock equivalents outstanding for the period in the denominator. At December 31, 2013 and 2012 any equivalents would have been anti-dilutive as we had losses for the periods then ended.
Research and Development	'
	Research and Development
	Expenditures for research activities relating to product development and improvement are charged to expense as incurred. We incurred $40,305 and $55,233 in research and development expenses for the nine months ended December 31, 2013 and 2012, respectively, and $31,866 and $43,004 in research and development expenses for the three months ended December 31, 2013 and 2012, respectively.
Rent Expense	'
	Rent Expense
	We recognize rent expense on a straight-line basis over the reasonably assured lease term as defined in ASC Topic 840, Leases (“ASC 840”). In addition, our lease agreement provides for rental payments commencing at a date other than the date of initial occupancy. We include the rent holidays in determination of straight-line rent expense. Therefore, rent expense is charged to expense beginning with the occupancy date. Deferred rent was $2,666 and $5,066 at December 31, 2013 and March 31, 2013, respectively, and will be charged to rent expense over the life of the lease.
Recent Pronouncements	'
	Recent Pronouncements
	We have reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoptions of any such pronouncements may be expected to cause a material impact on our financial condition or results of operations.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Summary of Estimated Useful Lives of Assets	'
	The estimated useful lives used for financial statement purposes are:
	Furniture and fixtures: 5 years
	Equipment: 7 years
	Leasehold improvements: 2 years

Property_Plant_and_Equipment_T

Property Plant and Equipment (Tables)	9 Months Ended
	Dec. 31, 2013
Property, Plant and Equipment [Abstract]	'
Major Classes of Property and Equipment	'
	Major classes of property and equipment consist of the following:
		31-Dec-13			31-Mar-13
	Furniture and fixtures	$	13,331		$	11,070
	Equipment		372,220			330,321
	Leasehold Improvements		3,300			3,300
			388,851			344,691
	Less: accumulated depreciation		(73,509	)		(33,195	)
		$	315,342		$	311,496

Intangible_Assets_Tables

Intangible Assets (Tables)	9 Months Ended
	Dec. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	'
	Estimated amortization expense related to the patent as of December 31, 2013 is as follows:
	Fiscal Years ending March 31,	Total Amortization
	2014 (three months remaining)	$	15,077
	2015		60,307
	2016		60,307
	2017		60,307
	2018		60,307
	Later years		457,022
		$	713,327

ShortTerm_Notes_Payable_Relate1

Short-Term Notes Payable (Related and Unrelated) (Tables) (Short Term Notes Payable [Member])	9 Months Ended
	Dec. 31, 2013
Schedule of Short Term Notes Payable	'
	The balance at December 31, 2013 was comprised of:
	Convertible notes payable, related and unrelated parties	$	775,000
	Unamortized Debt discount		(291,204	)
		$	483,796
Warrant [Member]	'
Schedule of fair value of the warrants Assumptions Used for Fair Value of Warrant	'
	The fair value of the warrant, $0.38 per share, was calculated using the Black-Sholes option pricing model using the following assumptions:
	Expected life (in years)		5
	Volatility (based on a comparable company)		97	%
	Risk Free interest rate		1.66	%
	Dividend yield (on common stock)		-

Convertible_Note_Related_and_U1

Convertible Note (Related and Unrelated) (Tables) (Convertible Notes Payable [Member])	9 Months Ended
	Dec. 31, 2013
Short-term Debt [Line Items]	'
Schedule of Convertible Note	'
	The balance at December 31, 2013 was comprised of:
	Convertible notes payable, related and unrelated parties	$	420,000
	Unamortized Debt discount		(247,316	)
		$	172,684
Schedule of Aggregate Amount of Principal Payments Due	'
	The aggregate amount of principal payments due as of December 31, 2013 are as follows:
	Fiscal Years ending March 31,
	2014	$	-
	2015		775,000
	2016		420,000
		$	1,195,000
Warrant [Member]	'
Short-term Debt [Line Items]	'
Schedule of Assumptions Used for Fair Value of Warrant	'
	The fair value of the warrants, $0.13 per share, ($216,531 in the aggregate) was calculated using the Black-Sholes option pricing model using the following assumptions:
	Expected life (in years)		3
	Volatility (based on a comparable company)		85	%
	Risk Free interest rate		0.91	%
	Dividend yield (on common stock)		-

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	9 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Summary of Aggregate Minimum Requirements Under Non-Cancelable Leases	'
	The aggregate minimum requirements under non-cancelable leases as of December 31, 2013 are as follows:
	Fiscal Years ending March 31,
	2014 (three months remaining)	$	19,995
	2015		46,655
		$	66,650

Stockholders_Equity_Tables

Stockholders' Equity (Tables)	9 Months Ended
	Dec. 31, 2013
Schedule of Fair Value of the Warrant Using the Black Sholes Option Pricing Model	'
	The following assumptions were used in the Black-Scholes option pricing model:
	Expected life (in years)		3 - 5
	Volatility (based on a comparable company)		87 - 106	%
	Risk Free interest rate		0.67 - 1.38	%
	Dividend yield (on common stock)		-
Summary of Outstanding Stock Options Issued	'
	The following is a summary of outstanding stock options issued to employees as of December 31, 2013
		Number of			Exercise		Average		Aggregate
		Options			price		remaining		intrinsic value
					per share		term in years		at date of grant
	Outstanding March 31, 2013		625,000		$	1		2.23	$	-
	Cancelled		(625,000	)		-		-		-
	Outstanding December 31, 2013		-			-		-		-
	Exercisable		-		$	-		-	$	-
Warrant [Member]	'
Schedule of Fair Value of the Warrant Using the Black Sholes Option Pricing Model	'
	The following assumptions were used in the Black-Scholes option pricing model:
	Expected life (in years)		3
	Volatility (based on a comparable company)		100	%
	Risk Free interest rate		0.36	%
	Dividend yield (on common stock)		-

Outstanding_Warrants_Tables

Outstanding Warrants (Tables)	9 Months Ended
	Dec. 31, 2013
Outstanding Warrants	'
Summary of Outstanding Warrants	'
	The following is a summary of all outstanding warrants as of December 31, 2013:
		Number of		Exercise		Average		Aggregate
		warrants		price		remaining		intrinsic value
				per share		term in years		at date of grant
	Warrants issued in connection with private placements of common stock		14,372,232	$	0.25 - 1.50		3.1	$	1,296,420
	Warrants issued in connection with private placement of convertible notes		2,636,519	$	0.25 - 0.46		2.68 - 4.65	$	-
	Warrants issued in connection with short-term notes payable		1,291,667	$	0.45		4.97	$	64,583

Summary_of_Significant_Account3

Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013
Accounting Policies [Abstract]	'	'	'	'	'
Development stage enterprise, deficit accumulated during development stage	$4,049,516	'	$4,049,516	'	'
Useful life of patent	'	'	'20 years	'	'
Research and development expenses	31,866	43,004	40,305	55,233	'
Deferred rent liability	$2,666	'	$2,666	'	$5,066

Summary_of_Significant_Account4

Summary of Significant Accounting Policies - Summary of Estimated Useful Lives of Assets (Details)	9 Months Ended
	Dec. 31, 2013
Furniture And Fixtures [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives	'5 years
Equipment [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives	'7 years
Leasehold Improvements [Member]	'
Property, Plant and Equipment [Line Items]	'
Estimated useful lives	'2 years

Property_Plant_and_Equipment_D

Property, Plant and Equipment (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Abstract]	'	'	'	'
Depreciation	$12,928	$9,846	$40,314	$15,801

Property_Plant_and_Equipment_M

Property, Plant and Equipment - Major Classes of Property and Equipment (Details) (USD $)	Dec. 31, 2013	Mar. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	$388,851	$344,691
Less: accumulated depreciation	-73,509	-33,195
Property, plant and equipment	315,342	311,496
Furniture And Fixtures [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	13,331	11,070
Equipment [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	372,220	330,321
Leasehold Improvements [Member]	'	'
Property, Plant and Equipment [Line Items]	'	'
Property, plant and equipment, gross	$3,300	$3,300

Intangible_Assets_Details_Narr

Intangible Assets (Details Narrative) (USD $)	Dec. 31, 2013	Mar. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'
Patent cost	$734,244	$37,087
Accumulated amortization on Patents	$20,917	$5,102

Intangible_Assets_Schedule_of_

Intangible Assets - Schedule of Finite-Lived Intangible Assets Future Amortization Expense (Details) (USD $)	Dec. 31, 2013	Mar. 31, 2013
Goodwill and Intangible Assets Disclosure [Abstract]	'	'
2014 (three months remaining)	$15,077	'
2015	60,307	'
2016	60,307	'
2017	60,307	'
2018	60,307	'
Later years	457,022	'
Intangible asset, net of amortization	$713,327	$31,985

Advance_from_Related_Party_Det

Advance from Related Party (Details Narrative) (USD $)	9 Months Ended	12 Months Ended
	Dec. 31, 2013	Mar. 31, 2013
Related Party Transactions [Abstract]	'	'
Cash received from affiliate	$445,157	'
Percentage of interest paid to related party	6.00%	'
Amount of Interest paid to related party	5,617	'
Advances to related party	$12,975	$30,272

ShortTerm_Notes_Payable_Relate2

Short-Term Notes Payable (Related and Unrelated) (Details Narrative) (USD $)	9 Months Ended					9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013	Dec. 31, 2013	Aug. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013
				Warrant [Member]	Warrant [Member]	Short Term Notes Payable [Member]	Short Term Notes Payable [Member]	Significant Shareholder [Memebr]	Officer, Director And Significant Shareholder [Member]	Director And Significant Shareholder [Member]
							Warrant [Member]
Proceeds from short term debt	$775,000	'	'	'	'	'	'	'	'	'
Notes payable to related parties current	436,985	'	'	'	'	'	'	500,000	100,000	100,000
Short term debt bear interest rate	2.00%	'	'	'	'	'	'	'	'	'
Notes payable due date	'	'	'	'	'	20-Dec-14	'	'	'	'
Number of Warrants Issued	'	'	'	'	'	1,291,667	'	'	'	'
Common stock, price per share	'	'	'	$0.25	$0.46	$0.45	'	'	'	'
Fair value of warrant per share	'	'	'	'	$0.13	'	$0.38	'	'	'
Amount recorded as debt discount	'	'	'	'	'	298,232	'	'	'	'
Estimated effective interest rate	'	'	'	'	'	52.00%	'	'	'	'
Interest rate per annum	'	'	'	'	'	2.00%	'	'	'	'
Accrued interest expenses	'	'	'	'	'	$467	'	'	'	'
Extended debt instruments maturity date	'	'	'	'	'	'	'	'	'	'
						extend the due date of the Short-Term Notes to June 19, 2014 with notice to the holders given at least 30 days and no more than 60 days prior to the initial due date
Short-Term Notes interest rate increase	3.00%	'	'	'	'	'	'	'	'	'
Extended warrants term	'3 years	'	'	'	'	'	'	'	'	'
Percentage of divided unpaid principal amount	'	'	'	'	'	56.25%	'	'	'	'

ShortTerm_Notes_Payable_Relate3

Short-Term Notes Payable (Related and Unrelated) - Schedule of Fair Value of Warrants Assumptions Used for Fair Value of Warrant (Details) (Warrant [Member])	9 Months Ended
	Dec. 31, 2013
Expected life (in years)	'3 years
Volatility (based on a comparable company)	85.00%
Risk Free interest rate	0.91%
Dividend yield (on common stock)	'
Short Term Notes Payable [Member]	'
Expected life (in years)	'5 years
Volatility (based on a comparable company)	97.00%
Risk Free interest rate	1.66%
Dividend yield (on common stock)	'

ShortTerm_Notes_Payable_Relate4

Short-Term Notes Payable (Related and Unrelated) - Schedule of Short Term Notes Payable (Details) (USD $)	Dec. 31, 2013
Convertible notes payable, related and unrelated parties	$420,000
Unamortized Debt discount	-247,316
Convertible notes payable	172,684
Short Term Notes Payable [Member]	'
Convertible notes payable, related and unrelated parties	775,000
Unamortized Debt discount	-291,204
Convertible notes payable	$483,796

Convertible_Note_Related_and_U2

Convertible Note (Related and Unrelated) (Details Narrative) (USD $)	9 Months Ended		1 Months Ended	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Aug. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Aug. 31, 2012
			Convertible Notes Payable [Member]	Convertible Notes Payable [Member]	Warrant [Member]	Warrant [Member]
Short-term Debt [Line Items]	'	'	'	'	'	'
Issuance of convertible notes	$20,000	$440,000	$440,000	$400,000	'	'
Notes purchased by significant shareholder	'	'	50,000	'	'	'
Notes bear interest rate	'	'	12.00%	12.00%	'	'
Notes payable due date	'	'	6-Sep-13	6-Sep-15	'	'
Conversion price	'	'	$0.37	'	'	'
Common stock, price per share	'	'	'	'	$0.25	$0.46
Number of Warrants Issued	'	'	956,519	1,680,000	'	'
Repayment of debt	40,000	'	'	40,000	'	'
Issuance of convertible notes other	'	'	'	20,000	'	'
Fair value of warrant per share	'	'	'	'	'	$0.13
Fair value aggregate amount	'	'	'	'	'	216,531
Amount recorded as debt discount	'	'	'	142,873	'	'
Convertible notes, beneficial conversion feature	125,905	142,019	'	125,905	'	'
Debt discount amortization period	'	'	'	'2 years	'	'
Estimated effective interest rate	'	'	'	74.00%	'	'
Interest rate per annum	'	'	'	12.00%	'	'
Accrued interest expenses	'	'	'	$16,017	'	'

Convertible_Note_Related_and_U3

Convertible Note (Related and Unrelated) - Schedule of Assumptions Used for Fair Value of Warrant (Details) (Warrant [Member])	9 Months Ended
	Dec. 31, 2013
Warrant [Member]	'
Expected life (in years)	'3 years
Volatility	85.00%
Risk Free interest rate	0.91%
Dividend yield (on common stock)	'

Convertible_Note_Related_and_U4

Convertible Note (Related and Unrelated) - Schedule of Debt (Details) (USD $)	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Convertible notes payable, related and unrelated parties	$420,000
Unamortized Debt discount	-247,316
Convertible notes payable	$172,684

Convertible_Note_Related_and_U5

Convertible Note (Related and Unrelated) - Schedule of Aggregate Amount of Principal Payments Due (Details) (USD $)	Dec. 31, 2013
Debt Disclosure [Abstract]	'
2014	'
2015	775,000
2016	420,000
Total	$1,195,000

Commitments_and_Contingencies_1

Commitments and Contingencies (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]	'	'	'	'
Lease expiration date	'	'	31-Oct-14	'
Lease rental expenses	$22,257	$19,601	$62,209	$21,984

Commitments_and_Contingencies_2

Commitments and Contingencies - Summary of Aggregate Minimum Requirements Under Non-Cancelable Leases (Details) (USD $)	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
2014 (three months remaining)	$19,995
2015	46,655
Total	$66,650

Stockholders_Equity_Details_Na

Stockholders' Equity (Details Narrative) (USD $)	1 Months Ended		9 Months Ended
	Aug. 31, 2013	31-May-13	Dec. 31, 2013	9-May-13
Class of Stock [Line Items]	'	'	'	'
Issuance of stock for services to non-employee, shares	'	'	1,850,000	'
Issuance of stock for services to non-employee	'	'	$596,500	'
Unamortized balance of vested portion not yet expensed	'	'	12,500	'
Issuance of additional shares	'	'	1,350,000	'
Share-based compensation	'	'	103,488	'
Sale of stock, price per share	'	'	$0.25	$0.25
Issuance of stock units description	'	'	'	'
	Each unit consists of one share of common stock, a three-year warrant to purchase one share of our common stock at an exercise price of $0.25 per share (which may be exercised on a cashless basis), and a five-year warrant to purchase one-half (1/2) share of our common stock at an exercise price of $0.50 per share (“Unit” or “Units)	Each unit consists of one share of common stock and a three year warrant to purchase one-half (1/2) share of our common stock at an exercise price of $0.50 per share (“Unit” or “Units”).
Exercise Price of Warrant	$0.50	'	'	'
Number of units sold	'	'	3,200,000	'
Number of shares and warrants issued	'	'	3,200,000	'
Stock issuable upon exercise of warrants	'	'	1,600,000	'
Stock units issued during period value	1,906,500	'	800,000	'
Stock issuance cost	267,645	'	17,500	'
Proceeds from stock units issued net of issuance cost	1,638,855	'	782,500	'
Fair Value Adjustment of Warrants	'	'	3,089,919	'
Warrant [Member]	'	'	'	'
Class of Stock [Line Items]	'	'	'	'
Fair Value Adjustment of Warrants	'	'	266,673	'
General and Administrative Expense [Member]	'	'	'	'
Class of Stock [Line Items]	'	'	'	'
Allocated share-based compensation expense	'	'	$14,747	'
Minimum [Member]	'	'	'	'
Class of Stock [Line Items]	'	'	'	'
Amortized over the periods of contracts	'	'	'1 year	'
Maximum [Member]	'	'	'	'
Class of Stock [Line Items]	'	'	'	'
Amortized over the periods of contracts	'	'	'2 years	'

Stockholders_Equity_Schedule_o

Stockholders' Equity - Schedule of Fair Value of Warrant Using Black Sholes Option Pricing Model (Details)	9 Months Ended
	Dec. 31, 2013
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Dividend yield (on common stock)	0.00%
Minimum [Member]	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Expected life (in years)	'3 years
Volatility (based on a comparable company)	87.00%
Risk Free interest rate	0.67%
Maximum [Member]	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Expected life (in years)	'5 years
Volatility (based on a comparable company)	106.00%
Risk Free interest rate	1.38%
Warrant [Member]	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'
Expected life (in years)	'3 years
Volatility (based on a comparable company)	100.00%
Risk Free interest rate	0.36%
Dividend yield (on common stock)	0.00%

Stockholders_Equity_Summary_of

Stockholders' Equity - Summary of Outstanding Stock Options Issued (Details) (Employee Stock Option [Member], USD $)	9 Months Ended
	Dec. 31, 2013
Employee Stock Option [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Options, Outstanding, Beginning balance	625,000
Number of Options, Cancelled	-625,000
Number of Options, Outstanding, Ending balance	'
Number of Options, Exercisable	'
Exercise price per share, Outstanding, Beginning balance	$1
Exercise price per share, Cancelled	'
Exercise price per share, Outstanding, Ending balance	'
Exercise price per share, Options, Exercisable	'
Average remaining term in years, Outstanding	'2 years 2 months 23 days
Average remaining term in years, Exercisable	'0 years
Aggregate intrinsic value at date of grant, Outstanding, Beginning balance	'
Aggregate intrinsic value at date of grant, Outstanding, Ending balance	'
Aggregate intrinsic value at date of grant, Exercisable	'

Outstanding_Warrants_Summary_o

Outstanding Warrants - Summary of Outstanding Warrants (Details) (Warrant [Member], USD $)	9 Months Ended
	Dec. 31, 2013
Short Term Notes Payable [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	1,291,667
Exercise price per share	$0.45
Average remaining term in years	'4 years 11 months 19 days
Aggregate intrinsic value at date of grant	$64,583
Convertible Notes Payable [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	2,636,519
Aggregate intrinsic value at date of grant	'
Minimum [Member] | Convertible Notes Payable [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Exercise price per share	$0.25
Average remaining term in years	'2 years 8 months 5 days
Maximum [Member] | Convertible Notes Payable [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Exercise price per share	$0.46
Average remaining term in years	'4 years 7 months 24 days
Private Placement [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Number of Warrants	14,372,232
Average remaining term in years	'3 years 1 month 6 days
Aggregate intrinsic value at date of grant	$1,296,420
Private Placement [Member] | Minimum [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Exercise price per share	$0.25
Private Placement [Member] | Maximum [Member]	'
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Exercise price per share	$1.50

Interest_Expense_Details_Narra

Interest Expense (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
Interest Expense	'	'	'	'
Interest expense	$18,067	$13,200	$48,474	$17,600
Interest expense, non-cash amortization of the debt discount	$25,217	$65,369	$146,839	$94,679